Kathleen Goin, Chief Operating Officer at PALVELLA THERAPEUTICS, INC. (PVLA), sold 4,302 shares at $147.14 ($642K) on 2026-07-15, disclosed to the SEC on 2026-07-17.
Scheduled sale ($642k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $147.14 | 522 | $77K | 12.0% |
| 2 | $148.40 | 840 | $125K | 19.4% |
| 3 | $149.27 | 1,029 | $154K | 23.9% |
| 4 | $150.25 | 1,911 | $287K | 44.7% |
| Total | $149.28 avg | 4,302 | $642K | 100% |
| Filing → |
| PVLA | SELL | 2026-06-22 | $476K | — | Filing → |
| PVLA | SELL | 2026-05-22 | $476K | — | Filing → |
| PVLA | SELL | 2026-04-17 | $547K | — | Filing → |